Tuesday, 02 January 2024 12:17 GMT

Medical Device Testing Services Market Size, Share, Trends And Forecast, 2026-2033 Market To Reach $20.2 Billion As Regulatory Complexity And Outsourcing Drive 8.5% CAGR


Date:

(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Nov. 03, 2026 (GLOBE NEWSWIRE) -- "Medical Device Testing Services Market Size, Share & Trends Analysis Report 2026-2033" has been added to ResearchAndMarkets.com's offering.

The global medical device testing services market was valued at USD 10.5 billion in 2025 and is expected to increase from USD 11.4 billion in 2026 to USD 20.2 billion by 2033. The market is projected to expand at a CAGR of 8.5% from 2026 to 2033, supported by increasingly rigorous regulatory requirements, expanding medical device production, and growing demand for specialized testing throughout the product lifecycle.

Asia Pacific led the global market with a revenue share of 41.6% in 2025. The region's leadership reflects its expanding medical device manufacturing base, increasing healthcare investment, and growing use of outsourced laboratory services. North America and Europe also represent significant markets due to established regulatory systems, continued medical technology innovation, and the adoption of risk-based product assessment frameworks.

Global regulators increasingly require comprehensive verification, validation, and safety assessments before medical devices can be commercialized. This regulatory focus is increasing demand for medical device testing services covering biocompatibility, chemistry, microbiology quality control, package validation, and other critical areas. The growing complexity of implantable devices, combination products, and digital health technologies is also creating opportunities for laboratories with advanced technical capabilities.

Software-enabled devices and connected medical technologies require manufacturers to address evolving quality, safety, and performance expectations. At the same time, increasing development activity involving complex materials and patient-contacting products is strengthening demand for biocompatibility testing and material characterization. Outsourcing these activities to specialized testing providers can help manufacturers access technical expertise, manage laboratory capacity, and support regulatory submissions across multiple markets.

Market Segmentation Covered in the Report

The report provides revenue analysis and forecasts at the global, regional, and country levels. It also examines industry trends across key market segments from 2021 to 2033, including service, phase, device class, industry application, end use, and region.

Service Outlook (Revenue, USD Billion, 2021 - 2033)

  • Biocompatibility testing services, including cytotoxicity, sensitization, irritation & reactivity, systemic toxicity, hemocompatibility, implantation, and pyrogenicity testing
  • Material / chemical characterization
  • Chemistry testing services, including analytical method development & validation, residuals & contaminant analysis, and stability & degradation studies
  • Microbiology QC testing services, including bioburden determination, bacterial endotoxin testing, and sterility testing & validation
  • Package validation services
  • Other specialized testing services

Phase Outlook (Revenue, USD Billion, 2021 - 2033)

  • Preclinical, including In Vivo Testing, Ex Vivo Testing, and In Vitro Testing
  • Clinical
  • Commercial

Device Class and Application Outlook

The analysis covers Class I, Class II, and Class III devices. Industry applications include cardiovascular, orthopedic, dental, neurological, ophthalmic, general surgical, aesthetic & dermatology, and other medical devices. This segmentation supports assessment of testing requirements across products with different risk profiles, materials, clinical applications, and regulatory pathways.

End Use Outlook (Revenue, USD Billion, 2021 - 2033)

  • Medical Device Manufacturers
  • CRO & CDM
  • Others

Regional Outlook (Revenue, USD Billion, 2021 - 2033)

The report evaluates the medical device testing services market across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Country-level coverage includes the U.S., Canada, Mexico, UK, Germany, France, Italy, Spain, Denmark, Sweden, Norway, Netherlands, Belgium, Switzerland, Japan, China, India, Australia, Thailand, South Korea, Malaysia, Indonesia, Singapore, Philippines, Brazil, Argentina, Colombia, Chile, South Africa, UAE, Saudi Arabia, Kuwait, Qatar, and Oman.

Key Benefits of the Report

  • Comprehensive market analysis: Assess revenue performance across major services, development phases, device classes, applications, end users, and geographic markets.
  • Competitive intelligence: Review the market presence and strategic positioning of key medical device testing service providers.
  • Growth trend assessment: Identify regulatory, technological, manufacturing, and outsourcing trends influencing future demand.
  • Strategic insights: Evaluate potential revenue opportunities and support informed investment, expansion, and business planning decisions.
  • Regional forecasting: Compare market potential across established and emerging countries.
  • Innovation tracking: Monitor service developments and testing capabilities affecting competition and customer requirements.

With demand rising for reliable verification, validation, safety, and quality testing, specialized service providers are positioned to play a larger role in global medical device commercialization. The report delivers market intelligence designed to support opportunity assessment, competitive strategy, market entry planning, and long-term decision-making.

Companies Featured

  • SGS SA
  • Laboratory Corporation of America Holdings
  • Sotera Health Company (Nelson Laboratories, LLC)
  • TUV SUD
  • Charles River Laboratories
  • Element Minnetonka
  • Eurofins Scientific
  • Pace Analytical Services LLC
  • Intertek Group Plc
  • North America Science Associates Inc. (NAMSA)

For more information about this report visit

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN03112026004107003653ID1111909964


GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.



More Story

Search